Logo image of PET

WAG! GROUP CO (PET) Stock Fundamental Analysis

NASDAQ:PET - Nasdaq - US93042P1093 - Common Stock - Currency: USD

0.2962  0 (-1.46%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PET. PET was compared to 71 industry peers in the Diversified Consumer Services industry. PET has a bad profitability rating. Also its financial health evaluation is rather negative. PET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PET has reported negative net income.
PET had a negative operating cash flow in the past year.
PET Yearly Net Income VS EBIT VS OCF VS FCFPET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

PET has a Return On Assets of -49.76%. This is amonst the worse of the industry: PET underperforms 85.94% of its industry peers.
With a Return On Equity value of -682.91%, PET is not doing good in the industry: 85.94% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -49.76%
ROE -682.91%
ROIC N/A
ROA(3y)-34.31%
ROA(5y)N/A
ROE(3y)-399.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PET Yearly ROA, ROE, ROICPET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -200 -400 -600 -800

1.3 Margins

PET has a better Gross Margin (91.73%) than 98.44% of its industry peers.
The Profit Margin and Operating Margin are not available for PET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PET Yearly Profit, Operating, Gross MarginsPET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

PET does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PET has more shares outstanding
Compared to 1 year ago, PET has a worse debt to assets ratio.
PET Yearly Shares OutstandingPET Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
PET Yearly Total Debt VS Total AssetsPET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -6.15, we must say that PET is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.15, PET is doing worse than 81.25% of the companies in the same industry.
There is no outstanding debt for PET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.15
ROIC/WACCN/A
WACC15.15%
PET Yearly LT Debt VS Equity VS FCFPET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

PET has a Current Ratio of 0.62. This is a bad value and indicates that PET is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.62, PET is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
PET has a Quick Ratio of 0.62. This is a bad value and indicates that PET is not financially healthy enough and could expect problems in meeting its short term obligations.
PET's Quick ratio of 0.62 is on the low side compared to the rest of the industry. PET is outperformed by 73.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
PET Yearly Current Assets VS Current LiabilitesPET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PET have decreased strongly by -84.21% in the last year.
Looking at the last year, PET shows a decrease in Revenue. The Revenue has decreased by -3.20% in the last year.
EPS 1Y (TTM)-84.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.43%

3.2 Future

Based on estimates for the next years, PET will show a very strong growth in Earnings Per Share. The EPS will grow by 29.53% on average per year.
Based on estimates for the next years, PET will show a very strong growth in Revenue. The Revenue will grow by 24.63% on average per year.
EPS Next Y22.09%
EPS Next 2Y24.03%
EPS Next 3Y29.53%
EPS Next 5YN/A
Revenue Next Year-5.6%
Revenue Next 2Y0.4%
Revenue Next 3Y26.34%
Revenue Next 5Y24.63%

3.3 Evolution

PET Yearly Revenue VS EstimatesPET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PET Yearly EPS VS EstimatesPET Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PET Price Earnings VS Forward Price EarningsPET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PET Per share dataPET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PET's earnings are expected to grow with 29.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.03%
EPS Next 3Y29.53%

More info and screens

0

5. Dividend

5.1 Amount

PET does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WAG! GROUP CO

NASDAQ:PET (2/21/2025, 8:00:00 PM)

0.2962

0 (-1.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)02-25 2025-02-25/amc
Inst Owners52.93%
Inst Owner Change-99.3%
Ins Owners11.94%
Ins Owner Change-8.21%
Market Cap14.75M
Analysts45
Price Target0.51 (72.18%)
Short Float %5.69%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-89.77%
Min EPS beat(2)-197.03%
Max EPS beat(2)17.49%
EPS beat(4)2
Avg EPS beat(4)-47.54%
Min EPS beat(4)-197.03%
Max EPS beat(4)21.37%
EPS beat(8)4
Avg EPS beat(8)-8.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-27.07%
Min Revenue beat(2)-37.45%
Max Revenue beat(2)-16.7%
Revenue beat(4)2
Avg Revenue beat(4)-11.8%
Min Revenue beat(4)-37.45%
Max Revenue beat(4)3.54%
Revenue beat(8)6
Avg Revenue beat(8)0.83%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-62.5%
EPS NQ rev (1m)-150%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.57%
Revenue NQ rev (1m)-12.77%
Revenue NQ rev (3m)-12.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.54
BVpS0.05
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.76%
ROE -682.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.73%
FCFM N/A
ROA(3y)-34.31%
ROA(5y)N/A
ROE(3y)-399.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.68%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z -6.15
F-Score4
WACC15.15%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y22.09%
EPS Next 2Y24.03%
EPS Next 3Y29.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.43%
Revenue Next Year-5.6%
Revenue Next 2Y0.4%
Revenue Next 3Y26.34%
Revenue Next 5Y24.63%
EBIT growth 1Y-32.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.93%
EBIT Next 3Y67.17%
EBIT Next 5Y60.71%
FCF growth 1Y-129.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.84%
OCF growth 3YN/A
OCF growth 5YN/A